SHOP: scaffold HOPping by GRID-based similarity searches.

A new GRID-based method for scaffold hopping (SHOP) is presented. In a fully automatic manner, scaffolds were identified in a database based on three types of 3D-descriptors. SHOP's ability to recover scaffolds was assessed and validated by searching a database spiked with fragments of known ligands of three different protein targets relevant for drug discovery using a rational approach based on statistical experimental design. Five out of eight and seven out of eight thrombin scaffolds and all seven HIV protease scaffolds were recovered within the top 10 and 31 out of 31 neuraminidase scaffolds were in the 31 top-ranked scaffolds. SHOP also identified new scaffolds with substantially different chemotypes from the queries. Docking analysis indicated that the new scaffolds would have similar binding modes to those of the respective query scaffolds observed in X-ray structures. The databases contained scaffolds from published combinatorial libraries to ensure that identified scaffolds could be feasibly synthesized.

[1]  F. Sanz,et al.  Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. , 2005 .

[2]  Ian W. Davis,et al.  Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.

[3]  Philip M. Dean,et al.  Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design , 1997, J. Comput. Aided Mol. Des..

[4]  Ramon Carbo,et al.  How similar is a molecule to another? An electron density measure of similarity between two molecular structures , 1980 .

[5]  K Osterlund,et al.  Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor. , 1997, Journal of medicinal chemistry.

[6]  C. Cavallaro,et al.  Allylindium and allylboronic acid pinacolate: Mild reagents for the allylation of resin-bound aldehydes. Application to the solid-phase synthesis of hydroxypropylamines , 1999 .

[7]  S. Pickett,et al.  GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.

[8]  O. Lavastre,et al.  Efficient solution phase combinatorial access to a library of pyrazole- and triazole-containing compounds. , 2003, Journal of combinatorial chemistry.

[9]  Philip M Dean,et al.  Scaffold hopping in de novo design. Ligand generation in the absence of receptor information. , 2004, Journal of medicinal chemistry.

[10]  R. Dolle,et al.  Comprehensive survey of combinatorial library synthesis: 1998. , 1999, Journal of combinatorial chemistry.

[11]  S Wold,et al.  Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors. , 2001, Journal of medicinal chemistry.

[12]  R. Dolle,et al.  Solid-phase synthesis of α-hydroxy phosphonates and hydroxystatine amides. Transition-state isosteres derived from resin-bound amino acid aldehydes , 2001 .

[13]  R. Dolle.  Comprehensive survey of combinatorial library synthesis: 2000. , 2001, Journal of combinatorial chemistry.

[14]  A. Hilgeroth.  Dimeric 4-Aryl-1,4-dihydropyridines: development of a third class of nonpeptidic HIV-1 protease inhibitors. , 2002, Mini reviews in medicinal chemistry.

[15]  R. Dolle.  Comprehensive survey of combinatorial library synthesis: 2001. , 2002, Journal of combinatorial chemistry.

[16]  Peter Willett,et al.  Scaffold Searching: Automated Identification of Similar Ring Systems for the Design of Combinatorial Libraries , 2002 .

[17]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[18]  D. Musil,et al.  Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: analysis of X-ray crystal structure of enzyme inhibitor complex. , 2003, Journal of medicinal chemistry.

[19]  Brian J. Smith,et al.  Analysis of inhibitor binding in influenza virus neuraminidase , 2001, Protein science : a publication of the Protein Society.

[20]  S Wold,et al.  Statistical molecular design of building blocks for combinatorial chemistry. , 2000, Journal of medicinal chemistry.

[21]  R. Dolle.  Comprehensive survey of combinatorial library synthesis: 2000. , 2001, Journal of combinatorial chemistry.

[22]  G. Schneider,et al.  Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. , 2001, Journal of combinatorial chemistry.

[23]  Qiang Zhang,et al.  Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.

[24]  P. Colman,et al.  The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor , 1992, Proteins.

[25]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[26]  Yong‐Chul Kim,et al.  Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: synthesis of ligands for somatostatin receptors. , 2003, Bioorganic & medicinal chemistry.

[27]  Ismael Zamora,et al.  Virtual Screening and Scaffold Hopping Based on GRID Molecular Interaction Fields , 2005, J. Chem. Inf. Model..

[28]  Alison J. Burnham,et al.  LATENT VARIABLE MULTIVARIATE REGRESSION MODELING , 1999 .

[29]  J H Matthews,et al.  Bound structures of novel P3-P1' beta-strand mimetic inhibitors of thrombin. , 1999, Journal of medicinal chemistry.

[30]  S. Wold.  Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models , 1978 .

[31]  Roland E Dolle,et al.  Comprehensive survey of combinatorial library synthesis: 2002. , 2003, Journal of combinatorial chemistry.

[32]  Wolfgang H. B. Sauer,et al.  Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..

[33]  Y. Kiso,et al.  HIV protease inhibitors: peptidomimetic drugs and future perspectives. , 2002, Current medicinal chemistry.

[34]  G. Chang,et al.  Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .

[35]  Roland E Dolle,et al.  Comprehensive survey of combinatorial library synthesis: 2003. , 2004, Journal of combinatorial chemistry.

[36]  M. Stone.  Cross‐Validatory Choice and Assessment of Statistical Predictions , 1976 .

[37]  D C Spellmeyer,et al.  Measuring diversity: experimental design of combinatorial libraries for drug discovery. , 1995, Journal of medicinal chemistry.

[38]  Yongliang Yang,et al.  Virtual Hydrocarbon and Combinatorial Databases for Use with CAVEAT , 2005, J. Chem. Inf. Model..

[39]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[40]  M. von Itzstein,et al.  Recent strategies in the search for new anti-influenza therapies. , 2003, Current drug targets.

[41]  Paul A. Bartlett,et al.  CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..

[42]  Andreas Zell,et al.  The Compressed Feature Matrix—a novel descriptor for adaptive similarity search , 2003, Journal of molecular modeling.

[43]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[44]  J. Jenkins,et al.  A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.

[45]  R. Dolle,et al.  Comprehensive survey of combinatorial library synthesis: 1999. , 2000, Journal of combinatorial chemistry.

[46]  J. S. Hunter,et al.  Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building. , 1979 .

[47]  Herman Wold,et al.  Soft modelling: The Basic Design and Some Extensions , 1982 .

[48]  C. Ehrhardt,et al.  Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors. , 1998, Journal of medicinal chemistry.

[49]  Werner Seitz,et al.  D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety. , 2003, Bioorganic & medicinal chemistry letters.